[go: up one dir, main page]

MX2009000657A - Composiciones y metodos para el tratamiento de mucositis. - Google Patents

Composiciones y metodos para el tratamiento de mucositis.

Info

Publication number
MX2009000657A
MX2009000657A MX2009000657A MX2009000657A MX2009000657A MX 2009000657 A MX2009000657 A MX 2009000657A MX 2009000657 A MX2009000657 A MX 2009000657A MX 2009000657 A MX2009000657 A MX 2009000657A MX 2009000657 A MX2009000657 A MX 2009000657A
Authority
MX
Mexico
Prior art keywords
methods
mucositis
compositions
treatment
compound
Prior art date
Application number
MX2009000657A
Other languages
English (en)
Inventor
Per Gjorstrup
C Eric Schwartz
Original Assignee
Resolvyx Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Resolvyx Pharmaceuticals Inc filed Critical Resolvyx Pharmaceuticals Inc
Publication of MX2009000657A publication Critical patent/MX2009000657A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A61K31/232—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms having three or more double bonds, e.g. etretinate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La presente invención se refiere a métodos para tratar mucositis, en donde los métodos comprenden administrar un compuesto de la fórmula A, un compuesto de cualesquiera de las fórmulas de la 1 a la 46, un compuesto de lipoxina, o un compuesto de oxilipina.
MX2009000657A 2006-07-19 2007-07-19 Composiciones y metodos para el tratamiento de mucositis. MX2009000657A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US83186606P 2006-07-19 2006-07-19
PCT/US2007/016338 WO2008011085A1 (en) 2006-07-19 2007-07-19 Compositions and methods for the treatment of mucositis

Publications (1)

Publication Number Publication Date
MX2009000657A true MX2009000657A (es) 2009-05-28

Family

ID=38617335

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2009000657A MX2009000657A (es) 2006-07-19 2007-07-19 Composiciones y metodos para el tratamiento de mucositis.

Country Status (14)

Country Link
US (1) US20100035989A1 (es)
EP (1) EP2049099A1 (es)
JP (1) JP2009545527A (es)
KR (1) KR20090040323A (es)
CN (1) CN101528218A (es)
AU (1) AU2007275658B2 (es)
BR (1) BRPI0714562A2 (es)
CA (1) CA2658361C (es)
IL (1) IL196465A0 (es)
MX (1) MX2009000657A (es)
RU (1) RU2009101324A (es)
SG (1) SG173397A1 (es)
WO (1) WO2008011085A1 (es)
ZA (1) ZA200900388B (es)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2400462C (en) 2000-02-16 2011-09-27 Brigham And Women's Hospital, Inc. Aspirin-triggered lipid mediators
US7902257B2 (en) * 2002-04-01 2011-03-08 University Of Southern California Trihydroxy polyunsaturated eicosanoid
US8481772B2 (en) * 2002-04-01 2013-07-09 University Of Southern California Trihydroxy polyunsaturated eicosanoid derivatives
US20100190735A1 (en) * 2006-03-28 2010-07-29 Myrex Pharmaceuticals Inc. Mouthwash and Method of Using Same for the Treatment of Mucositis or Stomatitis
EP2679224A1 (en) 2007-08-01 2014-01-01 University of Pittsburgh of the Commonwealth System of Higher Education Nitro oleic acid modulation of type II diabetes
KR20100080798A (ko) * 2007-10-12 2010-07-12 레솔빅스 파마슈티칼즈, 인코퍼레이티드 안과 질환의 치료를 위한 옥실리핀 화합물
CN102083787A (zh) 2008-05-01 2011-06-01 康普雷克萨公司 乙烯基取代的脂肪酸
WO2009155439A2 (en) 2008-06-19 2009-12-23 University Of Utah Research Foundation Use of nitrated lipids for treatment of side effects of toxic medical therapies
US20140024713A1 (en) 2008-06-19 2014-01-23 University Of Utah Research Foundation Use of nitrated lipids for treatment of side effects of toxic medical therapies
EP2393353A4 (en) * 2009-02-05 2013-12-25 Resolvyx Pharmaceuticals Inc COMPOSITIONS AND METHODS OF ORGAN CONSERVATION
WO2010095706A1 (ja) 2009-02-20 2010-08-26 国立大学法人東京大学 新規抗炎症性化合物
US9066902B2 (en) 2009-07-31 2015-06-30 University of Pittsburgh—of the Commonwealth System of Higher Education Fatty acids as anti-inflammatory agents
US8686167B2 (en) 2009-10-02 2014-04-01 Complexa, Inc. Heteroatom containing substituted fatty acids
EP2744491B1 (en) 2011-08-19 2020-07-29 The University of Utah Research Foundation Combination therapy with nitrated lipids and inhibitors of the renin-angiotensin-aldosterone system
WO2013116753A1 (en) * 2012-02-03 2013-08-08 University Of Pittsburgh-Of The Commonwelth System Of Higher Education Fatty acids as anti-inflammatory agents
CN103417471A (zh) * 2012-05-22 2013-12-04 吴升华 一种治疗湿疹等皮肤炎症的脂氧素乳膏
KR101621856B1 (ko) 2013-08-19 2016-05-17 한국생명공학연구원 모노아세틸디아실글리세롤 화합물을 유효성분으로 함유하는 류마티스 관절염의 예방 또는 치료용 조성물
EP3097910B1 (en) * 2014-01-24 2020-05-13 Kyoto University Anti-inflammatory agent containing rare fatty acid
CN114081876A (zh) 2014-05-15 2022-02-25 株式会社Enzychem生命科学 治疗白细胞减少症和血小板减少症的方法
CN112010861A (zh) 2015-07-07 2020-12-01 H.隆德贝克有限公司 用于治疗外周疾病的具有咪唑并三嗪酮骨架和咪唑并吡嗪酮骨架的pde9抑制剂
IL258476B2 (en) 2015-10-02 2023-04-01 Complexa Inc Prevention, treatment and reversal of disease using therapeutically effective amounts of activated fatty acids
US9808438B2 (en) * 2015-11-09 2017-11-07 Enzychem Lifesciences Corporation Method for treating mucositis
CA3100988A1 (en) 2018-05-25 2019-11-28 Imara Inc. Monohydrate and crystalline forms of 6-[(3s,4s)-4-methyl-1-(pyrimidin-2-ylmethyl)pyrrolidin-3-yl]-3-tetrahydropyran-4-yl-7h-imidazo[1,5-a]pyrazin-8-one
KR102831968B1 (ko) 2018-08-31 2025-07-08 카듀리온 파마슈티칼스, 인크. 겸상 세포 질환의 치료를 위한 pde9 억제제

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4576758A (en) * 1984-06-01 1986-03-18 The Upjohn Company Anti-inflammatory lipoxin B analogs
US6887901B1 (en) * 1993-06-15 2005-05-03 Brigham & Women's Hospital, Inc. Lipoxin compounds and their use in treating cell proliferative disorders
EP1162976B1 (en) * 1999-03-18 2010-05-05 The Brigham And Women's Hospital, Inc. 16-phenoxy-lipoxin analogs for medical use
CA2400462C (en) * 2000-02-16 2011-09-27 Brigham And Women's Hospital, Inc. Aspirin-triggered lipid mediators
US7700650B2 (en) * 2000-03-20 2010-04-20 Trustees Of Boston University Lipoxin analogs and method for the treatment of periodontal disease
WO2002070068A2 (en) * 2001-03-02 2002-09-12 The Brigham And Women's Hospital Lipoxin analogs as novel inhibitors of angiogenesis
AU2002349297A1 (en) * 2001-12-03 2003-06-17 Kobenhavns Amt Statin-like compounds
US7030159B2 (en) * 2001-12-18 2006-04-18 The Brigham And Women's Hospital, Inc. Approach to anti-microbial host defense with molecular shields with EPA and DHA analogs
EP1458373A1 (en) * 2001-12-18 2004-09-22 The Brigham and Women's Hospital Use of lipoxin analogs to promote cell defense against gram-negative infections
US7582785B2 (en) * 2002-04-01 2009-09-01 University Of Southern California Trihydroxy polyunsaturated eicosanoid derivatives
US6949664B2 (en) * 2002-04-01 2005-09-27 University Of Southern California Trihydroxy polyunsaturated eicosanoids
EP1537069B1 (en) * 2002-06-17 2008-01-02 Resolvyx Pharmaceuticals ANALOGUES OF LIPID MEDIATORS DERIVED FROM OMEGA-3 PUFAs AND METHODS OF USE
US7759395B2 (en) * 2002-08-12 2010-07-20 The Brigham And Women's Hospital, Inc. Use of docosatrienes, resolvins and their stable analogs in the treatment of airway diseases and asthma
AU2003258194B2 (en) * 2002-08-12 2009-11-12 The Brigham And Women's Hospital, Inc. Resolvins: biotemplates for therapeutic interventions
WO2004110426A1 (en) * 2003-06-01 2004-12-23 Petasis Nicos A Modulation of airway inflammation in patients with cystic fibrosis and related diseases
US20050203184A1 (en) * 2003-09-10 2005-09-15 Petasis Nicos A. Benzo lipoxin analogues
MX2007006049A (es) * 2004-11-19 2007-07-24 Martek Biosciences Corp Oxilipinas de acidos grasos poliinsaturados de cadena larga y metodos para elaborar y utilizar los mismos.
US20060293288A1 (en) * 2005-01-07 2006-12-28 Serhan Charles N Use of resolvins to treat gastrointestinal diseases

Also Published As

Publication number Publication date
KR20090040323A (ko) 2009-04-23
EP2049099A1 (en) 2009-04-22
CA2658361C (en) 2013-04-23
ZA200900388B (en) 2010-03-31
BRPI0714562A2 (pt) 2013-04-02
IL196465A0 (en) 2009-11-18
SG173397A1 (en) 2011-08-29
AU2007275658B2 (en) 2011-09-01
US20100035989A1 (en) 2010-02-11
JP2009545527A (ja) 2009-12-24
WO2008011085A1 (en) 2008-01-24
CN101528218A (zh) 2009-09-09
RU2009101324A (ru) 2010-07-27
CA2658361A1 (en) 2008-01-24
AU2007275658A1 (en) 2008-01-24

Similar Documents

Publication Publication Date Title
MX2009000657A (es) Composiciones y metodos para el tratamiento de mucositis.
PH12013500913A1 (en) Substituted-quinoxaline-type-piperidine compounds and the uses thereof
PT1984357E (pt) Compostos de 2,4-pirimidinadiamina para tratamento ou prevenção de doenças autoimunes
TW200716606A (en) Chemical compounds
TW200800963A (en) Chemical compounds
PL1853602T3 (pl) Związki chemiczne
PT1853588E (pt) Compostos químicos
MX2009003821A (es) Compuestos de n-aril pirazol para usarse contra la diabetes.
MY153948A (en) Substituted-quinoxaline-type bridged-piperidine compounds and the uses thereof
EA200970542A1 (ru) ИНГИБИТОРЫ ДЕЙСТВИЯ Akt
MX2007015863A (es) Inhibidores de esfingosina cinasa.
UA107783C2 (en) Isoindoline compounds for use in treating cancer
UA95310C2 (ru) Композиция, содержащая ингибитор chk1 и циклодекстрин, для лечения рака
MY149512A (en) Pyrazolylaminopyridine derivatives useful as kinase inhibitors
MX2011012366A (es) Mezclas fungicidas sinergeticas.
WO2007059154A3 (en) Treatment of cancers with acquired resistance to kit inhibitors
TNSN08370A1 (en) Tetrahydropyridothienopyrimidine compounds and methods of use thereof
TW200700071A (en) Novel use
IL193252A0 (en) N-hydroxyacrylamide compounds
DE602006010738D1 (de) Pyrroloä2,3-cüpyridinderivate
WO2010075280A3 (en) Coumarin-based compounds for the treatment of alzheimer's disease and cancer
IN2015DN03331A (es)
SG158091A1 (en) Imidazoazepinone compounds
MX2010007543A (es) Inhibidores de iap.
TW200714596A (en) Isotopically substituted proton pump inhibitors

Legal Events

Date Code Title Description
HH Correction or change in general
FA Abandonment or withdrawal